Cardiogen

Description

Cardiogen — Bioregulatory Tetrapeptide

Cardiogen is a short synthetic tetrapeptide classified among bioregulator peptides. It is supplied for in vitro laboratory research only.

Research context

Preclinical literature has examined Cardiogen in in vitro cardiac cell culture models, using gene-expression and cell-proliferation assay designs to characterise cardiomyocyte proliferation signalling and fibroblast activity. As a short bioregulatory peptide, it is also referenced in structure-activity assay designs alongside other tetrapeptides of this class, which are studied for sequence-specific effects on gene transcription in targeted cell-culture systems.

Specification

• Available sizes: 20mg
• Form: lyophilised powder
• Purity: ≥99% (HPLC)
• Testing: independently lot-tested by Horizon Analytical · Certificate of Analysis per lot

For laboratory research use only. This material is supplied to qualified researchers and institutions for in vitro investigational use. It is not a drug, food, cosmetic or medical device. It is not intended for human or veterinary use, for diagnosis, treatment, cure or prevention of any disease, or for any use outside a controlled laboratory environment. No statement on this site has been evaluated by the Food and Drug Administration. Keep out of reach of children.

Related Research

Compound family: NAD+, MOTS-c, Cartalax, Cortagen

Browse: Growth Factor & Endocrine Research · All Research Peptides

Reconstitution & Lab Testing: All products independently tested by Horizon Analytical. See our Reconstitution & Lab Testing FAQ. Reconstitution typically requires BAC Water.